Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)

CUSIP: 03753U106

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
127,672,507
Total 13F shares
29,708,993
Share change
+594,517
Total reported value
$528,224,019
Price per share
$17.78
Number of holders
79
Value change
+$9,616,309
Number of buys
45
Number of sells
27

Security key

03753U106

Report period

Q3 2018

Institutions

79

Top holders

10

Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
13F
Company
3.4%
4,328,289
$95,222,000 30 Jun 2018
13F
Cormorant Asset Management, LP
13F
Company
3.4%
4,312,498
$94,875,000 30 Jun 2018
13F
BlackRock Finance, Inc.
13F
Company
2.2%
2,798,968
$61,578,000 30 Jun 2018
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
1.4%
1,742,622
$38,338,000 30 Jun 2018
13F
Vivo Capital, LLC
13F
Company
1.1%
1,456,499
$32,043,000 30 Jun 2018
13F
FMR LLC
13F
Company
1.1%
1,343,140
$29,549,000 30 Jun 2018
13F
VANGUARD GROUP INC
13F
Company
1.1%
1,342,290
$29,530,000 30 Jun 2018
13F
STATE STREET CORP
13F
Company
0.95%
1,208,204
$26,581,000 30 Jun 2018
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.75%
961,683
$21,157,000 30 Jun 2018
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.73%
932,753
$20,520,000 30 Jun 2018
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
0.7%
900,000
$19,800,000 30 Jun 2018
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.7%
893,460
$19,656,000 30 Jun 2018
13F
Sofinnova Investments, Inc.
13F
Company
0.48%
615,802
$13,548,000 30 Jun 2018
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.48%
606,956
$13,353,000 30 Jun 2018
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.45%
577,616
$12,708,000 30 Jun 2018
13F
JENNISON ASSOCIATES LLC
13F
Company
0.45%
570,464
$12,550,000 30 Jun 2018
13F
NORTHERN TRUST CORP
13F
Company
0.33%
427,029
$9,395,000 30 Jun 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.28%
360,202
$7,924,000 30 Jun 2018
13F
NF Trinity Capital (Hong Kong) Ltd
13F
Company
0.28%
357,142
$7,857,000 30 Jun 2018
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.22%
281,000
$6,182,000 30 Jun 2018
13F
Opaleye Management Inc.
13F
Company
0.21%
265,000
$5,830,000 30 Jun 2018
13F
S.c.a. Candriam
13F
Individual
0.19%
240,000
$5,280,000 30 Jun 2018
13F
BAKER BROS. ADVISORS LP
13F
Company
0.15%
196,078
$4,314,000 30 Jun 2018
13F
Ghost Tree Capital, LLC
13F
Company
0.14%
185,000
$4,070,000 30 Jun 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.13%
172,179
$3,788,000 30 Jun 2018
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.13%
168,000
$3,696,000 30 Jun 2018
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.11%
134,900
$2,968,000 30 Jun 2018
13F
Bank of New York Mellon Corp
13F
Company
0.1%
127,167
$2,798,000 30 Jun 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.09%
113,035
$2,487,000 30 Jun 2018
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.09%
110,803
$2,438,000 30 Jun 2018
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.08%
102,443
$2,254,000 30 Jun 2018
13F
Eversept Partners, LP
13F
Company
0.08%
98,395
$2,164,690 30 Jun 2018
13F
ALPS ADVISORS INC
13F
Company
0.06%
81,182
$1,786,000 30 Jun 2018
13F
MORGAN STANLEY
13F
Company
0.06%
79,627
$1,752,000 30 Jun 2018
13F
DEUTSCHE BANK AG\
13F
Company
0.05%
69,922
$1,538,000 30 Jun 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
0.05%
69,007
$1,518,000 30 Jun 2018
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.05%
65,428
$1,439,000 30 Jun 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
64,670
$1,423,000 30 Jun 2018
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
55,741
$1,226,000 30 Jun 2018
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
55,271
$1,216,000 30 Jun 2018
13F
Russell Investments Group, Ltd.
13F
Company
0.04%
50,054
$1,101,000 30 Jun 2018
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.04%
46,916
$1,032,000 30 Jun 2018
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
40,200
$884,000 30 Jun 2018
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.03%
36,800
$810,000 30 Jun 2018
13F
VIRTUS ADVISERS, LLC
13F
Company
0.03%
36,223
$797,000 30 Jun 2018
13F
ADAMS STREET PARTNERS LLC
13F
Company
0.03%
36,194
$796,000 30 Jun 2018
13F
RHUMBLINE ADVISERS
13F
Company
0.03%
33,952
$747,000 30 Jun 2018
13F
VHCP Management II, LLC
13F
Company
0.02%
29,710
$654,000 30 Jun 2018
13F
Swiss National Bank
13F
Company
0.02%
29,300
$645,000 30 Jun 2018
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
27,514
$606,000 30 Jun 2018
13F

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q3 2018

As of 30 Sep 2018, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,708,993 shares. The largest 10 holders included Hillhouse Capital Management, Ltd., Cormorant Asset Management, LP, BlackRock Inc., Sectoral Asset Management Inc, Vanguard Group Inc, STATE STREET CORP, Vivo Capital, LLC, VICTORY CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 79 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders
73
Q3 2018 holders
79
Holder diff
6
Investor Q2 2018 Shares Q3 2018 Shares Share Diff Share Chg % Q2 2018 Value $ Q3 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .